West Paces Advisors Inc. Gilead Sciences, Inc. Transaction History

West Paces Advisors Inc.

$408 Billion
Q3 2024

A detailed history of West Paces Advisors Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, West Paces Advisors Inc. holds 2,247 shares of GILD stock, worth $202,656. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,247

Previous 2,247 -0.0%

Holding current value

$202,656

Previous $154 Million 22.2%

% of portfolio

0.05%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$71.58 - $87.29 $1,073 - $1,309	-15 Reduced 0.66%	2,247 $165 Million
Q4 2023 Jan 30, 2024	BUY	$73.27 - $83.09 $1,099 - $1,246	15 Added 0.67%	2,262 $183 Million
Q1 2023 Dec 18, 2023	BUY	$77.31 - $88.08 $2,705 - $3,082	35 Added 1.58%	2,247 $186 Million
Q4 2022 Dec 18, 2023	BUY	$62.32 - $89.47 $137,851 - $197,907	2,212 New	2,212 $190 Million
Q1 2022 Dec 18, 2023	SELL	$57.92 - $72.58 $2,027 - $2,540	-35 Reduced 1.56%	2,212 $132 Million
Q4 2021 Dec 19, 2023	BUY	$64.88 - $73.64 $74,741 - $84,833	1,152 Added 108.68%	2,212 $161 Million
Q2 2020 Dec 19, 2023	SELL	$72.34 - $84.0 $85,867 - $99,708	-1,187 Reduced 52.83%	1,060 $81.6 Million
Q1 2020 Dec 20, 2023	SELL	$62.63 - $80.22 $10,208 - $13,075	-163 Reduced 13.33%	1,060 $79.2 Million
Q1 2019 Dec 21, 2023	SELL	$62.53 - $70.05 $1,875 - $2,101	-30 Reduced 2.45%	1,193 $77.6 Million
Q3 2018 Dec 20, 2023	SELL	$71.28 - $78.92 $72,990 - $80,814	-1,024 Reduced 45.57%	1,223 $94.4 Million
Q2 2018 Dec 21, 2023	BUY	$64.88 - $75.68 $1,946 - $2,270	30 Added 2.51%	1,223 $86.6 Million
Q4 2017 Dec 21, 2023	SELL	$71.15 - $83.52 $11,028 - $12,945	-155 Reduced 11.5%	1,193 $85.5 Million
Q3 2017 Dec 21, 2023	BUY	$72.11 - $85.47 $5,336 - $6,324	74 Added 5.81%	1,348 $109 Million
Q2 2017 Dec 21, 2023	SELL	N/A	-163 Reduced 11.34%	1,274 $90.2 Million
Q1 2017 Dec 21, 2023	SELL	N/A	-1,081 Reduced 42.93%	1,437 $97.6 Million
Q4 2016 Dec 21, 2023	BUY	N/A	271	2,518 $180 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.

Account

West Paces Advisors Inc. Gilead Sciences, Inc. Transaction History